Absco Therapeutics, Inc.
Biotechnology company · Allston, Massachusetts, United States
Absco Therapeutics, Inc. is a biotechnology company headquartered in Allston, Massachusetts, United States. Its earliest recorded incorporation is in 2024. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $406,500 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2025.
Absco Therapeutics at a glance
What does Absco Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $406,500 in total (2025). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $5 million sold (2025).
Frequently asked questions about Absco Therapeutics
Where is Absco Therapeutics headquartered?
Absco Therapeutics, Inc. is headquartered in Allston, Massachusetts, United States.
What does Absco Therapeutics do?
Absco Therapeutics, Inc. is a biotechnology company.
When was Absco Therapeutics founded?
The earliest incorporation on record for Absco Therapeutics, Inc. is in 2024, according to public company registers.
Similar companies
- Concerto Biosciences, Inc.Allston, Massachusetts, United States
- Aperture Bio, Inc.Allston, Massachusetts, United States
- Boston Interactome, Inc.Allston, Massachusetts, United States
- PionEar Technologies, Inc.Allston, Massachusetts, United States
- Rowan Scientific CorpAllston, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences